Chadwick Jeremy G — SEC Form 4 filings
SEC reporting owner CIK 1388406. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-27.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-04 to 2026-05-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 33 legs across 10 filings — 200,501 shares, $15,807,147 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 52,975 shares @ $77.21 ($4,089,983) in Kymera Therapeutics, Inc., filed 2026-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | 11 | — | 33 legs · 200,501 sh · $15,807,147 | 26 |
Form 4 filings — Chadwick Jeremy G
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-27 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 3,730 @ $78.36 · Sale (S): 324 @ $79.17 · Sale (S): 3,800 @ $79.39 · Sale (S): 4,500 @ $80.02 · Sale (S): 551 @ $80.71 · Sale (S): 3,679 @ $81.50 · +1 more | EDGAR |
| 2026-04-24 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 100 @ $30.17 · Option exercise (M): 200 @ $43.50 · Sale (S): 300 @ $90 · Option exercise (M): 100 (derivative) @ $0 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 4,466 @ $30.17 · Option exercise (M): 785 @ $43.50 · Sale (S): 5,251 @ $90.00 · Option exercise (M): 1,300 @ $43.50 · Sale (S): 1,300 @ $90 · Option exercise (M): 4,466 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-01 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 7,600 @ $29.64 · Sale (S): 7,600 @ $85.38 · Option exercise (M): 14,640 @ $29.64 · Sale (S): 13,540 @ $85.41 · Sale (S): 1,100 @ $86.05 · Option exercise (M): 7,600 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 84,400 @ $29.64 · Sale (S): 22,756 @ $76.73 · Sale (S): 52,975 @ $77.21 · Sale (S): 8,214 @ $78.40 · Sale (S): 6,105 @ $79.87 · Sale (S): 1,200 @ $80.05 · +4 more | EDGAR |
| 2026-03-11 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 20,000 @ $43.50 · Sale (S): 1,765 @ $82.13 · Sale (S): 12,882 @ $83.10 · Sale (S): 11,111 @ $83.72 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 12,575 @ $0 · Sale (S): 549 @ $87.75 · Sale (S): 383 @ $88.50 · Sale (S): 1,107 @ $89.66 · Sale (S): 394 @ $84.00 · Sale (S): 2,017 @ $85.04 · +3 more | EDGAR |
| 2025-05-23 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 2,575 @ $29.30 | EDGAR |
| 2025-03-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 25,000 @ $0 · Sale (S): 1,131 @ $30.33 · Sale (S): 252 @ $31.00 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 2,575 @ $34.99 | EDGAR |
| 2024-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 13,425 @ $0 · Grant/award (A): 80,548 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1388406 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →